Literature DB >> 15512958

Acetylsalicylic acid reduces viral shedding induced by thermal stress.

Bryan M Gebhardt1, Emily D Varnell, Herbert E Kaufman.   

Abstract

PURPOSE: To investigate the effect of acetylsalicylic acid on ocular shedding of herpes simplex virus type 1 (HSV-1).
MATERIALS AND METHODS: Mice that were latent for the McKrae strain of HSV-1 were treated with acetylsalicylic acid, a nonspecific inhibitor of cyclooxygenases, either prophylactically or at the time of heat stress-induced viral reactivation. The effect of the drug on viral shedding in the tear film, infectious virus in the cornea and trigeminal ganglion, and viral DNA in the cornea and trigeminal ganglion was determined.
RESULTS: Acetylsalicylic acid inhibited heat stress-induced shedding of virus in the tears and reduced the numbers of corneal and trigeminal ganglion homogenates containing virus. Intraperitoneal therapeutic and oral prophylactic plus therapeutic treatments were similar in their ability to inhibit reactivation.
CONCLUSIONS: The results indicate that a cyclooxygenase inhibitor such as acetylsalicylic acid can reduce recurrent viral infection in mice. These findings may implicate prostaglandins as agents in the viral reactivation process and suggest that therapy to suppress viral reactivation using nontoxic inhibitors of prostaglandin synthesis may be effective in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512958     DOI: 10.1080/02713680490504588

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

Review 1.  Ocular surgery after herpes simplex and herpes zoster keratitis.

Authors:  Piotr Kanclerz; Jorge L Alio
Journal:  Int Ophthalmol       Date:  2020-09-10       Impact factor: 2.031

Review 2.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

3.  A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva.

Authors:  Manish Kumar; James M Hill; Christian Clement; Emily D Varnell; Hilary W Thompson; Herbert E Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-15       Impact factor: 4.799

Review 4.  Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections.

Authors:  Kumari Asha; Neelam Sharma-Walia
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

5.  Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice.

Authors:  Jie Yin; Zhenping Huang; Yuan Xia; Fei Ma; Li Jing Zhang; Heng Hui Ma; Li Li Wang
Journal:  Mol Vis       Date:  2009-06-14       Impact factor: 2.367

Review 6.  Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.

Authors:  Jody M Webre; James M Hill; Nicole M Nolan; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Victor Hsia; Donna M Neumann; Timothy P Foster; Walter J Lukiw; Hilary W Thompson
Journal:  J Biomed Biotechnol       Date:  2012-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.